• 主题
高级搜索  >
历史搜索 清空历史
首页> 外国专利> METHOD FOR PREDICTING THE DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE WITHIN 12 MONTHS AFTER DECOMPENSATION OF CHRONIC HEART INSUFFICIENCY

METHOD FOR PREDICTING THE DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE WITHIN 12 MONTHS AFTER DECOMPENSATION OF CHRONIC HEART INSUFFICIENCY

机译：在慢性心脏功能不全，在交错后12个月内预测冠心病患者患者不良心血管事件的培养方法

页面导航
  • 摘要
  • 著录项
  • 相似文献

摘要

FIELD: medicine. ;SUBSTANCE: invention relates to biotechnology and medicine and can be used in cardiology, angiology, cardiac surgery, therapy, rehabilitology. The concentration of cytomegalovirus DNA per 1 ml of blood plasma is determined by polymerase chain reaction (PCR) with hybridization-fluorescence detection of amplification products in the real-time mode. If the concentration of cytomegalovirus DNA is more than 1418 copies/ml per 1 ml of blood plasma in patients with coronary heart disease, a high risk of developing adverse cardiovascular events is predicted during the next 12 months of follow-up. ;EFFECT: proposed method makes it possible to predict the development of adverse cardiovascular events in patients with coronary heart disease during 12 months of follow-up after discharge from the hospital for decompensation of chronic heart insufficiency, which makes it possible to identify a priority group of patients with an increased risk of cardiovascular complications for follow-up monitoring. ;1 cl, 1 dwg, 5 tbl, 1 ex
机译：领域：医学。 ;物质：发明涉及生物技术和药物，可用于心脏病学，血液学，心脏手术，治疗，康复学。每1mL血浆的缩细胞病毒DNA的浓度通过聚合酶链反应（PCR）测定，在实时模式下具有杂交 - 荧光检测扩增产物。如果冠心病患者每1ml血浆浓度大于1418份/ ml，则在未来12个月后预测发生不良心血管事件的高风险。 ;效果：提出的方法使得可以预测冠心病患者的不良心血管事件在从医院排出后的12个月后的患者中，从医院分解慢性心脏功能不全，这使得可以识别优先级随访监测的心血管并发症风险增加的患者。 ; 1 cl，1 dwg，5 tbl，1例

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号